Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Medium Chain Acyl CoA Dehydrogenase Deficiency”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableLooking for participantsNCT04602325
What this trial is testing

Systemic Biomarkers of Brain Injury From Hyperammonemia

Who this might be right for
Urea Cycle DisorderOrganic AcidemiaMaple Syrup Urine Disease+3 more
Children's National Research Institute 24
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Early research (Phase 1)Study completedNCT01881984
What this trial is testing

Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation

Who this might be right for
Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency
University of Pittsburgh 4
Very early researchStudy completedNCT05411835
What this trial is testing

Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders

Who this might be right for
Long-chain 3-hydroxyacyl-CoA Dehydrogenase DeficiencyCarnitine Palmitoyltransferase Deficiency 2Very Long Chain Acyl Coa Dehydrogenase Deficiency+1 more
Oregon Health and Science University 5
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Testing effectiveness (Phase 2)Study completedNCT00983788
What this trial is testing

Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects

Who this might be right for
Carnitine Palmitoyltransferase II DeficiencyVery Long Chain Acyl Coa Dehydrogenase Deficiency
Rigshospitalet, Denmark 12
Testing effectiveness (Phase 2)Temporarily pausedNCT06067802
What this trial is testing

Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Who this might be right for
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Jerry Vockley, MD, PhD 8
Testing effectiveness (Phase 2)Temporarily pausedNCT06069375
What this trial is testing

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Who this might be right for
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Jerry Vockley, MD, PhD 24
Testing effectiveness (Phase 2)Looking for participantsNCT06773026
What this trial is testing

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Who this might be right for
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Jerry Vockley, MD, PhD 24
Not applicableUnknownNCT03761693
What this trial is testing

Fasting Tolerance in MCADD-infants

Who this might be right for
Mcad Deficiency
University Medical Center Groningen 20
Not applicableActive Not RecruitingNCT04632953
What this trial is testing

Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05933200
What this trial is testing

Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 69
Not applicableEnded earlyNCT04812106
What this trial is testing

Long-Chain Fatty Acid Oxidation Disorders Online Disease Monitoring Program

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 8
Testing effectiveness (Phase 2)Study completedNCT01494051
What this trial is testing

High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders

Who this might be right for
Very Long-chain Acyl-CoA Dehydrogenase DeficiencyTrifunctional Protein DeficiencyCarnitine Palmitoyltransferase 2 Deficiency+1 more
Oregon Health and Science University 13
Not applicableUnknownNCT05910151
What this trial is testing

Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan

Who this might be right for
Propionic/Methylmalonic AcidemiasMaple Syrup Urine DiseaseCitrullinemia+26 more
West Kazakhstan Medical University 2,250
Not applicableUnknownNCT02635269
What this trial is testing

Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy

Who this might be right for
Metabolism, Inborn ErrorsLipid Metabolism, Inborn ErrorsCarbohydrate Metabolism, Inborn Errors+20 more
Rigshospitalet, Denmark 60
Testing effectiveness (Phase 2)Looking for participantsNCT07097311
What this trial is testing

Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Who this might be right for
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Jerry Vockley, MD, PhD 24
Not applicableStudy completedNCT00328159
What this trial is testing

Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids

Who this might be right for
Inborn Errors of Metabolism
Assistance Publique - Hôpitaux de Paris 20
Not applicableAvailableNCT03773770
What this trial is testing

Expanded Access to Triheptanoin

Who this might be right for
Long Chain Fatty Acid Oxidation Disorders
Ultragenyx Pharmaceutical Inc
Not applicableLooking for participantsNCT06623032
What this trial is testing

Metabolic Effects of Medium-Chain Fatty Acids in Patients with Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals

Who this might be right for
Medium-chain Acyl-CoA Dehydrogenase Deficiency
University of Copenhagen 30
Load More Results